Fundz

Consegna Pharma Acquires Fathom Pharma To Strengthen Initiatives That Address The Opioid Crisis

PRIVATEApr 19, 2022

Acquiring Company

Consegna Pharma

Acquired Company

Fathom Pharma

BiotechnologyHealth CareScience And EngineeringBiotechnologyHealth CareScience And Engineering

Description

Consegna Pharma Inc., a drug delivery company providing solutions to reduce deaths from opioid overdoses, is pleased to announce the acquisition of Fathom Pharma LLC, a company developing long-acting pain medicines.

Quick answer

Consegna Pharma is acquiring Fathom Pharma, announced April 19, 2022.

How much did Consegna Pharma pay for Fathom Pharma?
The deal value was not disclosed.
What does Consegna Pharma do?
Consegna Pharma is a leader in leveraging computational technologies to create long-acting injectable (LAI) drug delivery systems.

Source: Fundz verified event record.

Other recent acquisitions in Science And Engineering and Science And Engineering

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Consegna Pharma, and when

When Consegna Pharma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Consegna Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Consegna Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Consegna Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Consegna Pharma

About

Consegna Pharma is a leader in leveraging computational technologies to create long-acting injectable (LAI) drug delivery systems. Consegna is building a franchise of new medicines to help combat the opioid crisis. Consegna's product pipeline focuses on areas where LAIs offer high therapeutic value, such as addressing high non-adherence, solving specific drug delivery challenges, or reducing side effects. The company leverages its artificial intelligence (AI)-based Computational Drug DeliveryTM technology to design LAIs faster than legacy practice and with reduced clinical and technical risk.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Consegna Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Consegna Pharma's next move

Learn about Strategic plan

Frequently asked

Who acquired Fathom Pharma?

Fathom Pharma was acquired by Consegna Pharma. The deal was reported on April 19, 2022. Consegna Pharma is a leader in leveraging computational technologies to create long-acting injectable (LAI) drug delivery systems. Consegna is building a franchise of new medicines to help combat the opioid crisis. Consegna Pharma is privately held and operates in Biotechnology.

When did Consegna Pharma acquire Fathom Pharma?

Consegna Pharma's acquisition of Fathom Pharma was reported on April 19, 2022. Consegna Pharma Inc., a drug delivery company providing solutions to reduce deaths from opioid overdoses, is pleased to announce the acquisition of Fathom Pharma LLC, a company developing long-acting pain medicines. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Fathom Pharma do?

Fathom Pharma is focused on developing new treatments for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.